MINDSPACE Strategy for Risk Optimization

NACompletedINTERVENTIONAL
Enrollment

641

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Stroke
Interventions
BEHAVIORAL

Standard

"Investigators will develop a standard informational stroke risk message that will not undergo iterative review. This will inform the patient that based on information in the healthcare system, the patient is at higher risk of stroke than many others receiving care in the patient's healthcare system; it will describe options for working with their health care team to reduce the risk of stroke; and encourage the patient to call the health navigator to discuss these options and make a decision about next steps to take to reduce the patient's risk of stroke."

BEHAVIORAL

Incentive

Investigators anticipate that the baseline incentive stroke risk message will inform the patient that they are at higher risk of stroke than many others receiving care in the patient's healthcare system, and will provide information about obtaining an incentive if the patient calls to make contact with a health navigator who will help them plan a next step to reduce their stroke risk. The investigators also anticipate including information that all patients who call will also be entered in a random drawing to receive an additional incentive, with up to six patients receiving this incentive.

BEHAVIORAL

Salience

"Investigators anticipate that the baseline salience stroke risk message will inform the patient that they are at higher risk of stroke than many other patients receiving care in the patient's healthcare system, and will specifically focus on the patient's own risk factors (rather than all stroke risk factors). The salience message will also include visual depictions of stroke patients that are gender and ethnically matched to each subject. This is intended to prompt action by emphasizing that stroke is a real possibility for patients like me."

BEHAVIORAL

Incentive + Salience

Combined message of incentive plus salience.

Trial Locations (1)

46202

Richard L. Roudebush VA Medical Center, Indianapolis

Sponsors
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

collaborator

Regenstrief Institute, Inc.

OTHER

collaborator

Richard L. Roudebush VA Medical Center

FED

lead

Indiana Institute for Medical Research

OTHER